Signaling Pathways for Arsenic-Stimulated Vascular Endothelial Growth Factor-A Expression in Primary Vascular Smooth Muscle Cells

Chemical Research in Toxicology

Volumn 17, Issue 4, 2004, Pages 555-563

  Soucy, Nicole V ^a   Klei, Linda R ^a   Mayka, Deborah D ^a   Barchowsky, Aaron ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; DIACYLGLYCEROL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PROTEIN KINASE C DELTA; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ARSENIC POISONING; ARTICLE; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; HYPERTENSION; ISCHEMIC HEART DISEASE; NONHUMAN; PERIPHERAL VASCULAR DISEASE; SMOOTH MUSCLE FIBER; SWINE; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARSENIC; CHELATING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MUSCLE, SMOOTH, VASCULAR; RISK FACTORS; RNA, MESSENGER; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; SWINE; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 1942422185     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx034193q     Document Type: Article

References (69)

1. Abernathy, C. O., Liu, Y. P., Longfellow, D., Aposhian, H. V., Beck, B., Fowler, B., Goyer, R., Menzer, R., Rossman, T., Thompson, C., and Waalkes, M. (1999) Arsenic: health effects, mechanisms of actions, and research issues. Environ. Health Perspect. 107, 593-597.
2. Karagas, M. R., Stukel, T. A., and Tosteson, T. D. (2002) Assessment of cancer risk and environmental levels of arsenic in New Hampshire. Int. J. Hyg. Environ. Health 205, 85-94.
3. Rahman, M., Tondel, M., Ahmad, S. A., and Axelson, O. (1998) Diabetes mellitus associated with arsenic exposure in Bangladesh. Am. J. Epidemiol. 148, 198-203.
4. Lewis, D. R., Southwick, J. W., Ouellet-Hellstrom, R., Rench, J., and Calderon, R. L. (1999) Drinking Water Arsenic in Utah: A Cohort Mortality Study. Environ. Health Perspect. 107, 359-365.
5. Chen, C. J., Chiou, H. Y., Chiang, M. H., Lin, L. J., and Tai, T. Y. (1996) Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler., Thromb., Vasc. Biol. 16, 504-510.
6. Tseng, C. H., Chong, C. K., Chen, C. J., Lin, B. J., and Tai, T. Y. (1995) Abnormal peripheral microcirculation in seemingly normal subjects living in blackfoot-disease-hyperendemic villages in Taiwan. Int. J. Microcirc. Clin. Exp. 15, 21-27.
7. Wu, M. M., Kuo, T. L., Hwang, Y. H., and Chen, C. J. (1989) Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 130, 1123-1132.
8. Engel, R. R., Hopenhayn-Rich, C., Receveur, O., and Smith, A. H. (1994) Vascular effects of chronic arsenic exposure: a review. Epidemiologic Rev. 16, 184-208.
9. Tseng, C. H., Chong, C. K., Tseng, C. P., Hsueh, Y. M., Chiou, H. Y., Tseng, C. C., and Chen, C. J. (2003) Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol. Lett. 137, 15-21.
10. Wang, C. H., Jeng, J. S., Yip, P. K., Chen, C. L., Hsu, L. I., Hsueh, Y. M., Chiou, H. Y., Wu, M. M., and Chen, C. J. (2002) Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 105, 1804-1809.
11. Hertz-Picciotto, I., Arrighi, H. M., and Hu, S. W. (2000) Does arsenic exposure increase the risk for circulatory disease? Am. J. Epidemiol. 151, 174-181.
12. Zaldivar, R. (1980) A morbid condition involving cardio-vascular, broncho-pulmonary, digestive and neural lesions in children and young adults after dietary arsenic exposure. Zentralbl. Bakteriol. 170, 44-56.
13. Calderon, R. L. (2000) The epidemiology of chemical contaminants of drinking water. Food Chem. Toxicol. 38, S13-S20.
14. Engel, R. R., and Smith, A. H. (1994) Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch. Environ. Health 49, 418-427.
15. Li, Y., Sun, X., Wang, L., Zhou, Z., and Kang, Y. J. (2002) Myocardial toxicity of arsenic trioxide in a mouse model. Cardiovasc. Toxicol. 2, 63-73.
16. Unnikrishnan, D., Dutcher, J. P., Varshneya, N., Lucariello, R., Api, M., Garl, S., Wiernik, P. H., and Chiaramida, S. (2001) Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood 97, 1514-1516.
17. Ohnishi, K., Yoshida, H., Shigeno, K., Nakamura, S., Fujisawa, S., Naito, K., Shinjo, K., Fujita, Y., Matsui, H., Takeshita, A., Sugiyama, S., Satoh, H., Terada, H., and Ohno, R. (2000) Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann. Intern. Med. 133, 881-885.
18. Carmignani, M., Boscolo, P., and Castellino, N. (1985) Metabolic fate and cardiovascular effects of arsenic in rats and rabbits chronically exposed to trivalent and pentavalent arsenic. Arch. Toxicol. Suppl. 8, 452-455.
19. Lee, M. Y., Jung, B. I., Chung, S. M., Bae, O. N., Lee, J. Y., Park, J. D., Yang, J. S., Lee, H., and Chung, J. H. (2003) Arsenic-induced dysfunction in relaxation of blood vessels. Environ. Health Perspect. 111, 513-517.
20. Barchowsky, A., Dudek, E. J., Treadwell, M. D., and Wetterhahn, K. E. (1996) Arsenic Induces Oxidant Stress And NF-KappaB Activation In Cultured Aortic Endothelial Cells. Free Radical Biol. Med. 21, 783-790.
21. Barchowsky, A., Roussel, R. R., Klei, L. R., James, P. E., Ganju, N., Smith, K. R., and Dudek, E. J. (1999) Low Levels of Arsenic Trioxide Stimulate Proliferative Signals in Primary Vascular Cells without Activating Stress Effector Pathways. Toxicol. Appl. Pharmacol. 159, 65-75.
22. Kao, Y. H., Yu, C. L., Chang, L. W., and Yu, H. S. (2003) Low Concentrations of Arsenic Induce Vascular Endothelial Growth Factor and Nitric Oxide Release and Stimulate Angiogenesis In Vitro. Chem. Res. Toxicol. 16, 460-468.
23. Roboz, G. J., Dias, S., Lam, G., Lane, W. J., Soignet, S. L., Warrell, R. P., Jr., and Rafii, S. (2000) Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood 96, 1525-1530.
24. Duyndam, M. C., Hulscher, T. M., Fontijn, D., Pinedo, H. M., and Boven, E. (2001) Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite. J. Biol. Chem. 276, 48066-48076.
25. Duyndam, M. C., Hulscher, S. T., van der, W. E., Pinedo, H. M., and Boven, E. (2003) Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. J. Biol. Chem. 278, 6885-6895.
26. Robinson, C. J., and Stringer, S. E. (2001) The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 114, 853-865.
27. Ferrara, N., and Davis-Smyth, T. (1997) The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4-25.
28. Carmeliet, P., and Jain, R. K. (2000) Angiogenesis in cancer and other diseases. Nature 407, 249-257.
29. Gu, Y.-Z., Hogenesch, J. B., and Bradfield, C. A. (2000) The PAS superfamily: Sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40, 519-561.
30. Brogi, E., Schatteman, G., Wu, T., Kim, E. A., Varticovski, L., Keyt, B., and Isner, J. M. (1996) Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest. 97, 469-476.
31. Semenza, G. L. (2002) Angiogenesis in Ischemic and Neoplastic Disorders. Annu. Rev. Med. 54, 17-28.
32. Hossain, M. A., Bouton, C. M., Pevsner, J., and Laterra, J. (2000) Induction of vascular endothelial growth factor in human astrocytes by lead. Involvement of a protein kinase C/activator protein-1 complex-dependent and hypoxia-inducible factor 1-independent signaling pathway. J. Biol. Chem. 275, 27874-27882.
33. Bates, D. O., Lodwick, D., and Williams, B. (1999) Vascular endothelial growth factor and microvascular permeability. Microcirculation 6, 83-96.
34. Kim, B. S., Chen, J., Weinstein, T., Noiri, E., and Goligorsky, M. S. (2002) VEGF expression in hypoxia and hyperglycemia: reciprocal effect on branching angiogenesis in epithelial-endothelial co-cultures. J. Am. Soc. Nephrol. 13, 2027-2036.
35. Poulaki, V., Qin, W., Joussen, A. M., Hurlbut, P., Wiegand, S. J., Rudge, J., Yancopoulos, G. D., and Adamis, A. P. (2002) Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J. Clin. Invest. 109, 805-815.
36. Namiki, A., Brogi, E., Kearney, M., Kim, E. A., Wu, T., Couffinhal, T., Varticovski, L., and Isner, J. M. (1995) Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem. 270, 31189-31195.
37. Brogi, E., Wu, T., Namiki, A., and Isner, J. M. (1994) Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90, 649-652.
38. Williams, B., Gallacher, B., Patel, H., and Orme, C. (1997) Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 46, 1497-1503.
39. Hoshi, S., Nomoto, K., Kuromitsu, J., Tomari, S., and Nagata, M. (2002) High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem. Biophys. Res. Commun. 290, 177-184.
40. Bode, A. M., and Dong, Z. (2002) The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit. Rev. Oncol. Hematol. 42, 5-24.
41. Ross, R. (1971) The smooth muscle cell. J. Cell. Biol. 50, 172-185.
42. Andrew, A. S., Klei, L. R., and Barchowsky, A. (2001) Nickel requires hypoxia-inducible factor-1α, not redox signaling to induce plasminogen activator inhibitor-1. Am. J. Physiol. 281, L607-L615.
43. Shumilla, J. A., and Barchowsky, A. (1999) Inhibition of protein synthesis by Chromium(VI) differentially affects expression of urokinase and its receptor in human type II pneumocytes. Toxicol. Appl. Pharmacol. 158, 288-295.
44. Roussel, R. R., and Barchowsky, A. (2000) Arsenic Inhibits NF-kappaB-mediated Gene Transcription by Blocking IkappaB Kinase Activity and IkappaBalpha Phosphorylation and Degradation. Arch. Biochem. Biophys. 377, 204-212.
45. Namiki, A., Brogi, E., Kearney, M., Kim, E. A., Wu, T., Couffinhal, T., Varticovski, L., and Isner, J. M. (1995) Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem. 270, 31189-31195.
46. Deneke, S. M. (1992) Induction of cystine transport in bovine pulmonary artery endothelial cells by sodium arsenite. Biochim. Biophys. Acta 1109, 127-131.
47. Vega, L., Styblo, M., Patterson, R., Cullen, W., Wang, C., and Germolec, D. (2001) Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 172, 225-232.
48. Zhu, H., and Bunn, H. F. (2001) Signal transduction. How do cells sense oxygen? Science 292, 449-451.
49. Richard, D. E., Berra, E., and Pouyssegur, J. (2000) Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem. 275, 26765-26771.
50. Sowter, H. M., Raval, R., Moore, J., Ratcliffe, P. J., and Harris, A. L. (2003) Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res. 63, 6130-6134.
51. Chen, N. Y., Ma, W. Y., Huang, C., Ding, M., and Dong, Z. (2000) Activation of PKC is required for arsenite-induced signal transduction. J. Environ. Pathol. Toxicol. Oncol. 19, 297-305.
52. Kikkawa, U., Matsuzaki, H., and Yamamoto, T. (2002) Protein Kinase Cdelta (PKCdelta): Activation Mechanisms and Functions. J. Biochem. (Tokyo) 132, 831-839.
53. Lynn, S., Shiung, J.-N., Gurr, J. R., and Jan, K. Y. (1998) Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide. Free Radical Biol. Med. 24, 442-449.
54. Lynn, S., Gurr, J. R., Lai, H. T., and Jan, K. Y. (2000) NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ. Res. 86, 514-519.
55. Soucy, N. V., Ihnat, M. A., Kamat, C. D., Hess, L., Post, M. J., Klei, L. R., Clark, C., and Barchowsky, A. (2003) Arsenic stimulates angiogenesis and tumorigeneis in vivo. Toxicol. Sci. 76, 271-279.
56. Barchowsky, A., Klei, L. R., Dudek, E. J., Swartz, H. M., and James, P. E. (1999) Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radical Biol. Med. 27, 1405-1412.
57. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22.
58. Goto, F., Goto, K., Weindel, K., and Folkman, J. (1993) Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab. Invest. 69, 508-517.
59. Andrew, A. S., Warren, A. J., Barchowsky, A., Temple, K. A., Klei, L., Soucy, N. V., O'Hara, K. A., and Hamilton, J. W. (2003) Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environ. Health Perspect. 111, 825-835.
60. Liu, Y. S., Guyton, K. Z., Gorospe, M., Xu, Q. B., Lee, J. C., and Holbrook, N. J. (1996) Differential Activation Of ERK, JNK/SAPK And P38/CSBP/RK Map Kinase Family Members During The Cellular Response To Arsenite. Free Radical Biol. Med. 21, 771-781.
61. Wiesener, M. S., Jurgensen, J. S., Rosenberger, C., Scholze, C. K., Horstrup, J. H., Warnecke, C., Mandriota, S., Bechmann, I., Frei, U. A., Pugh, C. W., Ratcliffe, P. J., Bachmann, S., Maxwell, P. H., and Eckardt, K. U. (2003) Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J. 17, 271-273.
62. Maynard, M. A., Qi, H., Chung, J., Lee, E. H., Kondo, Y., Hara, S., Conaway, R. C., Conaway, J. W., and Ohh, M. (2003) Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J. Biol. Chem. 278, 11032-11040.
63. Naruse, K., and King, G. L. (2000) Protein kinase C and myocardial biology and function. Circ. Res. 86, 1104-1106.
64. Kunisaki, M., Fumio, U., Nawata, H., and King, G. L. (1996) Vitamin E normalizes diacylglycerol-protein kinase C activation induced by hyperglycemia in rat vascular tissues. Diabetes 45 (Suppl. 3), S117-S119.
65. Koya, D., and King, G. L. (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47, 859-866.
66. Joseloff, E., Cataisson, C., Aamodt, H., Ocheni, H., Blumberg, P., Kraker, A. J., and Yuspa, S. H. (2002) Src family kinases phosphorylate protein kinase C delta on tyrosine residues and modify the neoplastic phenotype of skin keratinocytes. J. Biol. Chem. 277, 12318-12323.
67. Blake, R. A., Garcia-Paramio, P., Parker, P. J., and Courtneidge, S. A. (1999) Src promotes PKCdelta degradation. Cell Growth Differ. 10, 231-241.
68. Shizukuda, Y., Tang, S., Yokota, R., and Ware, J. A. (1999) Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cdelta activity. Circ. Res. 85, 247-256.
69. Smith, K. R., Klei, L. R., and Barchowsky, A. (2001) Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am. J. Physiol. 280, L442-L449.